Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-01-16

FDA Approved: PRUCALOPRIDE — Original Application (Ajanta Pharma USA Inc.)

View source ↗

Summary

FDA approves Ajanta Pharma USA's original ANDA for prucalopride (generic) for the treatment of chronic idiopathic constipation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PRUCALOPRIDE (Prucalopride)

Snippet

ORIG AP for PRUCALOPRIDE (PRUCALOPRIDE)